Pay in 4 interest-free payments of $6.45 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
FDA-approved weight management injections are indicated for adults with a BMI 30 kg/m (obesity) or 27 kg/m with at least one weight-related comorbidity (such as hypertension, type 2 diabetes, or dyslipidemia)
The legal basis for compounded tirzepatide availability is the FDA's ongoing shortage designation for tirzepatide, which has been active since late 2023
Medical professionals explain that safety depends not only on the medication itself but also on the integrity of the supply chain
10.1038/s41569-020-0348-1 18
10.1016/j.redox.2016.12.022 189 XieW.ZhuT.ZhouP.XuH.MengX.DingT.et al (2020)
US$ 21.16
US$ 21.69
US$ 21.78
US$ 29.24
US$ 21.53
US$ 27.10
US$ 24.58
US$ 22.94
US$ 25.50
US$ 29.40
US$ 20.86
US$ 25.95
